AI 100
AI Capital
AI industry map
AI ETFs
Language
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
Sign in / Sign up
AI 100
AI Capital
AI industry map
AI ETFs
Language
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
← Back to investors
Taikang Life Insurance(泰康人寿)
保险机构
Website ↗
Verified investment lower bound
≥$57.02M
Investment cases
3
Manager operating history
—
Representative investments
智谱(Z.ai)
$28.46B
↗
MiniMax
$7.16B
↗
Insilico Medicine(英矽智能)
$2.65B
↗
Portfolio
Project activity
Investor contributions
Specific funds
About
Search
#
Company
Market cap / valuation
USD
Total funding
USD
Last financing / listing
Key investors
11
智谱(Z.ai)
2513.HK · 中国
$28.46B
Market capitalization
Market date not provided
Sources · 1
香港交易及結算所有限公司、香港聯合交易所有限公司(「聯交所」)及香港中央結算有限公司(「香港結算」)對本公 ↗
2026-10-22
≥$1.25B
Verified lower bound
IPO / listing
2026-01-08
凌云光
进益(天津)资产管理有限公司
WT Asset Management
3W Fund Management
Optimas Capital Limited
JSC International Investment Fund SPC – Qizhi SP
Other investors · 55
Perseverance Asset Management International (Singapore) Pte. Ltd.
上海高毅资产管理合伙企业(有限合伙)
Taikang Life Insurance(泰康人寿)
GF Fund Management(广发基金)
Rime Capital(雾凇)
Bosera Asset Management (International)(博时国际)
Fullgoal Fund Management(富国基金)
Haitong International Asset Management (HK)(海通国际资管)
China Asset Management(华夏基金)
BOCOM International Asset Management(交银国际资管)
天创投资
珠海华发
联想创投
夏睿投资
Legend Capital
北京市人工智能产业投资基金
杭州城投产业基金
高新策源
上城领航
智慧领航
星连肇基
中关村科学城二期
大兴产业基金
海河富新优达基金
小锋科技
厦门雅恒
无锡云晖
招商数科
Prosperity7 Ventures
联融致远
湖北5G基金
Ant Group
Fortune Capital
Qiming Venture Partners
青岛华控
天津合远
北京顺赢
欣欣相融
宁波明恒
多项网络
Tencent
杭州光合
上海飞玡
Capital Today
上海云玡
腾讯投资
Meituan(美团)
全德美嘉
天津三快
通智投资
北京华控
荣品投资
将门创投
南京图灵
创新智源
28
MiniMax
0100.HK · 中国
$7.16B
Market capitalization
Market date not provided
Sources · 1
MiniMax Group Inc. ↗
2026-10-22
≥$1.56B
Verified lower bound
IPO / listing
2026-01-09
Alibaba
miHoYo
IDG Capital
Tencent
Hillhouse
HongShan
Other investors · 20
Shunwei Capital
MPC VII Pte. Ltd.
Future Capital
Pacific Century Group
Abu Dhabi Investment Authority(ADIA)
Aspex Management (HK) Limited
Boyu Capital Management (Singapore) Pte. Ltd.(博裕)
China Universal Asset Management (Hong Kong)(汇添富香港)
Eastspring Investments (Singapore)
E Fund Management(易方达基金)
IDG Breyer Capital Fund L.P.
Janchor Partners Limited(健瓴投资)
Pulsating Star GP Limited
Mirae Asset Securities Co., Ltd.
Perseverance Asset Management International (Singapore) Pte. Ltd.
Taikang Life Insurance(泰康人寿)
Bosera Asset Management (International)(博时国际)
China Asset Management(华夏基金)
ICBC UBS Asset Management (International)(工银瑞信国际)
CITIC Securities Asset Management(中信证券资管)
55
Insilico Medicine(英矽智能)
3696.HK · 美国/中国
$2.65B
Market capitalization
Market date not provided
Sources · 1
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO ↗
2026-10-22
≥$110M
Verified lower bound
IPO / listing
2025-12-30
Value Partners PE Fund
Eli Lilly
Tencent
Oaktree Capital Management
Schroders(施罗德)
Temasek
Other investors · 14
UBS
China Asset Management(华夏基金)
Pacific Asset Management(太平洋资产)
CPIC Investment Management HK
E Fund Management(易方达基金)
Fullgoal Fund Management(富国基金)
Harvest Global Investments(嘉实国际)
Taikang Life Insurance(泰康人寿)
RTW Investments
Exome Asset Management
Infini Capital Management(无极资本)
Capital Group
Mirae Asset Securities Co., Ltd.
OrbiMed Advisors IV Limited